Educational information only. At Precursor, blood testing is requested and reviewed by a clinician and considered alongside your history and other markers, not as a stand-alone diagnosis. Testing is performed in NATA-accredited laboratories to ISO 15189 standards.
What is ApoB?
Apolipoprotein B, or ApoB, is a protein found on the surface of every cholesterol-carrying particle that can lodge in artery walls, including LDL, VLDL and lipoprotein(a). Because each of these particles carries exactly one ApoB, measuring it effectively counts the number of atherogenic particles in your blood.
Why it matters
Standard cholesterol tests measure the amount of cholesterol inside particles, not how many particles there are. ApoB measures the particle count directly, which many consider the most accurate single marker of lipid-related cardiovascular risk. It can reveal hidden risk in people whose LDL looks acceptable but who carry many small, cholesterol-poor particles.
What your results can mean
Higher than optimal
A high ApoB signals a large number of particles able to drive plaque, even when LDL appears in range. It is increasingly used to fine-tune risk and to guide how aggressively lipids should be managed.
Within the optimal range
A lower ApoB reflects fewer atherogenic particles overall, which is favourable for long-term arterial health. As with other lipids, the ideal target depends on your personal cardiovascular risk.
Reference ranges in Australia
ApoB is reported in grams per litre (g/L). As a general guide, values below roughly 0.8 to 0.9 g/L are often considered favourable, with lower targets for those at higher cardiovascular risk. Read your result against the range on your own report and in the context of your overall risk.
Test your ApoB with Precursor
ApoB adds precision that standard cholesterol can miss. At Precursor it is measured as part of Full Advanced Bloods, a single clinician-reviewed blood draw covering your heart, metabolic, hormonal, kidney, liver, thyroid and nutrient markers together, giving you and your clinician a sharper lipid picture and a baseline to track.
